{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,13]],"date-time":"2026-01-13T15:26:58Z","timestamp":1768318018730,"version":"3.49.0"},"reference-count":42,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2010,12,24]],"date-time":"2010-12-24T00:00:00Z","timestamp":1293148800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Pharm Res"],"published-print":{"date-parts":[[2011,6]]},"DOI":"10.1007\/s11095-010-0352-y","type":"journal-article","created":{"date-parts":[[2010,12,23]],"date-time":"2010-12-23T20:25:28Z","timestamp":1293135928000},"page":"1385-1394","source":"Crossref","is-referenced-by-count":13,"title":["The Effect of Human Bone Marrow Stroma-Derived Heparan Sulfate on the Ex Vivo Expansion of Human Cord Blood Hematopoietic Stem Cells"],"prefix":"10.1007","volume":"28","author":[{"given":"Diah S.","family":"Bramono","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David A.","family":"Rider","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sadasivam","family":"Murali","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Victor","family":"Nurcombe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Simon M.","family":"Cool","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2010,12,24]]},"reference":[{"issue":"1 Suppl 1","key":"352_CR1","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.bbmt.2005.09.006","volume":"12","author":"V Rocha","year":"2006","unstructured":"Rocha V, Gluckman E. Clinical use of umbilical cord blood hematopoietic stem cells. Biol Blood Marrow Transplant. 2006;12(1 Suppl 1):34\u201341.","journal-title":"Biol Blood Marrow Transplant"},{"issue":"2","key":"352_CR2","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1111\/j.1365-2141.2009.07883.x","volume":"147","author":"V Rocha","year":"2009","unstructured":"Rocha V, Gluckman E. Improving outcomes of cord blood transplantation: HLA matching, cell dose and other graft- and transplantation-related factors. Br J Haematol. 2009;147(2):262\u201374.","journal-title":"Br J Haematol"},{"key":"352_CR3","doi-asserted-by":"crossref","unstructured":"Gratwohl A, Baldomero H, Schwendener A, et al. The EBMT activity survey 2008 impact of team size, team density and new trends. Bone Marrow Transplant. 2010:1\u20138. doi: 10.1038\/bmt.2010.69","DOI":"10.1038\/bmt.2010.69"},{"issue":"2","key":"352_CR4","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1038\/nm.2080","volume":"16","author":"C Delaney","year":"2010","unstructured":"Delaney C, Heimfeld S, Brashem-Stein C, Voorhies H, Manger RL, Bernstein ID. Notch-mediated expansion of human cord blood progenitor cells capable of rapid myeloid reconstitution. Nat Med. 2010;16(2):232\u20136.","journal-title":"Nat Med"},{"issue":"7","key":"352_CR5","doi-asserted-by":"crossref","first-page":"828","DOI":"10.1016\/j.exphem.2005.03.017","volume":"33","author":"CL Silva da","year":"2005","unstructured":"da Silva CL, Goncalves R, Crapnell KB, Cabral JMS, Zanjani ED, Almeida-Porada G. A human stromal-based serum-free culture system supports the ex vivo expansion\/maintenance of bone marrow and cord blood hematopoietic stem\/progenitor cells. Exp Hematol. 2005;33(7):828\u201335.","journal-title":"Exp Hematol"},{"issue":"3","key":"352_CR6","first-page":"363","volume":"13","author":"S Angeli De","year":"2004","unstructured":"De Angeli S, Di Liddo R, Buoro S, Toniolo L, Conconi MT, Belloni AS, et al. New immortalized human stromal cell lines enhancing in vitro expansion of cord blood hematopoietic stem cells. Int J Mol Med. 2004;13(3):363\u201371.","journal-title":"Int J Mol Med"},{"issue":"8","key":"352_CR7","doi-asserted-by":"crossref","first-page":"3229","DOI":"10.1182\/blood.V87.8.3229.bloodjournal8783229","volume":"87","author":"P Gupta","year":"1996","unstructured":"Gupta P, McCarthy JB, Verfaillie CM. Stromal fibroblast heparan sulfate is required for cytokine-mediated ex vivo maintenance of human long-term culture-initiating cells. Blood. 1996;87(8):3229\u201336.","journal-title":"Blood"},{"issue":"6","key":"352_CR8","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1634\/stemcells.20-6-573","volume":"20","author":"S Kadereit","year":"2002","unstructured":"Kadereit S, Deeds LS, Haynesworth SE, Koc ON, Kozik MM, Szekely E, et al. Expansion of LTC-ICs and maintenance of p21 and BCL-2 expression in cord blood CD34(+)\/CD38(\u2212) early progenitors cultured over human MSCs as a feeder layer. Stem Cells. 2002;20(6):573\u201382.","journal-title":"Stem Cells"},{"issue":"1","key":"352_CR9","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1532\/IJH97.04080","volume":"81","author":"M Kobune","year":"2005","unstructured":"Kobune M, Kawano Y, Kato J, Ito Y, Chiba H, Nakamura K, et al. Expansion of CD34(+) cells on telomerized human stromal cells without losing erythroid-differentiation potential in a serum-free condition. Int J Hematol. 2005;81(1):18\u201325.","journal-title":"Int J Hematol"},{"key":"352_CR10","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1002\/jcp.1041130414","volume":"1","author":"TM Dexter","year":"1982","unstructured":"Dexter TM. Stromal cell associated haemopoiesis. J Cell Physiol Suppl. 1982;1:87\u201394.","journal-title":"J Cell Physiol Suppl"},{"issue":"6162","key":"352_CR11","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1038\/332376a0","volume":"332","author":"R Roberts","year":"1988","unstructured":"Roberts R, Gallagher J, Spooncer E, Allen TD, Bloomfield F, Dexter TM. Heparan sulphate bound growth factors: a mechanism for stromal cell mediated haemopoiesis. Nature. 1988;332(6162):376\u20138.","journal-title":"Nature"},{"issue":"4","key":"352_CR12","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1182\/blood.V85.4.997.bloodjournal854997","volume":"85","author":"BA Roecklein","year":"1995","unstructured":"Roecklein BA, Torokstorb B. Functionally distinct human marrow stromal cell-lines immortalized by transduction with the human papilloma-virus E6\/E7 genes. Blood. 1995;85(4):997\u20131005.","journal-title":"Blood"},{"issue":"7","key":"352_CR13","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1038\/icb.2008.49","volume":"86","author":"DR Coombe","year":"2008","unstructured":"Coombe DR. Biological implications of glycosaminoglycan interactions with haemopoietic cytokines. Immunol Cell Biol. 2008;86(7):598\u2013607.","journal-title":"Immunol Cell Biol"},{"issue":"6111","key":"352_CR14","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1038\/326403a0","volume":"326","author":"MY Gordon","year":"1987","unstructured":"Gordon MY, Riley GP, Watt SM, Greaves MF. Compartmentalization of a haematopoietic growth factor (GM-CSF) by glycosaminoglycans in the bone marrow microenvironment. Nature. 1987;326(6111):403\u20135.","journal-title":"Nature"},{"issue":"7139","key":"352_CR15","doi-asserted-by":"crossref","first-page":"1030","DOI":"10.1038\/nature05817","volume":"446","author":"JR Bishop","year":"2007","unstructured":"Bishop JR, Schuksz M, Esko JD. Heparan sulphate proteoglycans fine-tune mammalian physiology. Nature. 2007;446(7139):1030\u20137.","journal-title":"Nature"},{"key":"352_CR16","volume-title":"Essentials of Glycobiology","author":"JD Esko","year":"2008","unstructured":"Esko JD, Linhardt RJ. Proteins that bind sulfated glycosaminoglycans. In: Varki A, Cummings RD, Esko JD, Freeze HH, Stanley P, Bertozzi CR, Hart GW, Etzler ME, editors. Essentials of Glycobiology. La Jolla: Cold Spring Harbor Laboratory Press; 2008."},{"key":"352_CR17","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1007\/s10735-007-9123-4","volume":"38","author":"V Nurcombe","year":"2007","unstructured":"Nurcombe V, Goh FJ, Haupt LM, Murali S, Cool SM. Temporal and functional changes in glycosaminoglycan expression during osteogenesis. J Mol Histol. 2007;38:469\u201381.","journal-title":"J Mol Histol"},{"issue":"3","key":"352_CR18","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1002\/jcp.21825","volume":"220","author":"LM Haupt","year":"2009","unstructured":"Haupt LM, Murali S, Mun FK, Teplyuk N, Mei LF, Stein GS, et al. The heparan sulfate proteoglycan (HSPG) glypican-3 mediates commitment of MC3T3-E1 cells toward osteogenesis. J Cell Physiol. 2009;220(3):780\u201391.","journal-title":"J Cell Physiol"},{"issue":"4","key":"352_CR19","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1089\/scd.2008.0157","volume":"18","author":"C Dombrowski","year":"2009","unstructured":"Dombrowski C, Song SJ, Chuan P, Lim X, Susanto E, Sawyer AA, et al. Heparan sulfate mediates the proliferation and differentiation of rat mesenchymal stem cells. Stem Cells Dev. 2009;18(4):661\u201370.","journal-title":"Stem Cells Dev"},{"issue":"5","key":"352_CR20","doi-asserted-by":"crossref","first-page":"1132","DOI":"10.1002\/jcb.22340","volume":"108","author":"S Murali","year":"2009","unstructured":"Murali S, Manton KJ, Tjong V, Su XD, Haupt LM, Cool SM, et al. Purification and characterization of heparan sulfate from human primary osteoblasts. J Cell Biochem. 2009;108(5):1132\u201342.","journal-title":"J Cell Biochem"},{"issue":"9","key":"352_CR21","doi-asserted-by":"crossref","first-page":"2410","DOI":"10.1182\/blood.V83.9.2410.2410","volume":"83","author":"H Mayani","year":"1994","unstructured":"Mayani H, Lansdorp PM. Thy-l expression is linked to functional properties of primitive hematopoietic progenitor cells from human umbilical cord blood. Blood. 1994;83(9):2410\u20137.","journal-title":"Blood"},{"issue":"3","key":"352_CR22","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1182\/blood.V75.3.589.589","volume":"75","author":"DM Lewinsohn","year":"1990","unstructured":"Lewinsohn DM, Nagler A, Ginzton N, Greenberg P, Butcher EC. Hematopoietic progenitor cell expression of the H-CAM (CD44) homing-associated adhesion molecule. Blood. 1990;75(3):589\u201395.","journal-title":"Blood"},{"issue":"5403","key":"352_CR23","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1126\/science.283.5403.845","volume":"283","author":"A Peled","year":"1999","unstructured":"Peled A, Petit I, Kollet O, Magid M, Ponomaryov T, Byk T, et al. Dependence of human stem cell engraftment and repopulation of NOD\/SCID mice on CXCR4. Science. 1999;283(5403):845\u20138.","journal-title":"Science"},{"key":"352_CR24","first-page":"7","volume":"4","author":"R Schofield","year":"1978","unstructured":"Schofield R. The relationship between the spleen colony-forming cell and the haematopoietic stem cell. Blood Cells. 1978;4:7\u201325.","journal-title":"Blood Cells"},{"issue":"5","key":"352_CR25","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.1182\/blood.V67.5.1333.1333","volume":"67","author":"TN Wight","year":"1986","unstructured":"Wight TN, Kinsella MG, Keating A, Singer JW. Proteoglycans in human long-term bone marrow cultures\u2014biochemical and ultrastructural analyses. Blood. 1986;67(5):1333\u201343.","journal-title":"Blood"},{"issue":"42","key":"352_CR26","doi-asserted-by":"crossref","first-page":"24941","DOI":"10.1074\/jbc.270.42.24941","volume":"270","author":"YG Brickman","year":"1995","unstructured":"Brickman YG, Ford MD, Small DH, Bartlett PF, Nurcombe V. Heparan sulfates mediate the binding of basic fibroblast growth factor to a specific receptor on neural precursor cells. J Biol Chem. 1995;270(42):24941\u20138.","journal-title":"J Biol Chem"},{"issue":"9","key":"352_CR27","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1038\/nsmb811","volume":"11","author":"W Li","year":"2004","unstructured":"Li W, Johnson DJD, Esmon CT, Huntington JA. Structure of the antithrombin-thrombin-heparin ternary complex reveals the antithrombotic mechanism of heparin. Nat Struct Mol Biol. 2004;11(9):857\u201362.","journal-title":"Nat Struct Mol Biol"},{"issue":"4","key":"352_CR28","doi-asserted-by":"crossref","first-page":"2444","DOI":"10.1074\/jbc.M108540200","volume":"277","author":"O Ostrovsky","year":"2002","unstructured":"Ostrovsky O, Berman B, Gallagher J, Mulloy B, Fernig DG, Delehedde M, et al. Differential effects of heparin saccharides on the formation of specific fibroblast growth factor (FGF) and FGF receptor complexes. J Biol Chem. 2002;277(4):2444\u201353.","journal-title":"J Biol Chem"},{"issue":"12","key":"352_CR29","first-page":"3781","volume":"50","author":"SD Luikart","year":"1990","unstructured":"Luikart SD, Maniglia CA, Furcht LT, McCarthy JB, Oegema Jr TR. A heparan sulfate-containing fraction of bone marrow stroma induces maturation of HL-60 cells in vitro. Cancer Res. 1990;50(12):3781\u20135.","journal-title":"Cancer Res"},{"issue":"18","key":"352_CR30","doi-asserted-by":"crossref","first-page":"13100","DOI":"10.1016\/S0021-9258(17)36804-7","volume":"269","author":"RD Sanderson","year":"1994","unstructured":"Sanderson RD, Turnbull JE, Gallagher JT, Lander AD. Fine structure of heparan sulfate regulates syndecan-1 function and cell behavior. J Biol Chem. 1994;269(18):13100\u20136.","journal-title":"J Biol Chem"},{"issue":"44","key":"352_CR31","doi-asserted-by":"crossref","first-page":"43229","DOI":"10.1074\/jbc.M300937200","volume":"278","author":"T Takada","year":"2003","unstructured":"Takada T, Katagiri T, Ifuku M, Morimura N, Kobayashi M, Hasegawa K, et al. Sulfated polysaccharides enhance the biological activities of bone morphogenetic proteins. J Biol Chem. 2003;278(44):43229\u201335.","journal-title":"J Biol Chem"},{"issue":"12","key":"352_CR32","doi-asserted-by":"crossref","first-page":"4641","DOI":"10.1182\/blood.V92.12.4641","volume":"92","author":"P Gupta","year":"1998","unstructured":"Gupta P, Oegema TR, Brazil JJ, Dudek AZ, Slungaard A, Verfaillie CM. Structurally specific heparan sulfates support primitive human hematopoiesis by formation of a multimolecular stem cell niche. Blood. 1998;92(12):4641\u201351.","journal-title":"Blood"},{"issue":"1","key":"352_CR33","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1182\/blood.V95.1.147","volume":"95","author":"P Gupta","year":"2000","unstructured":"Gupta P, Oegema Jr TR, Brazil JJ, Dudek AZ, Slungaard A, Verfaillie CM. Human LTC-IC can be maintained for at least 5 weeks in vitro when interleukin-3 and a single chemokine are combined with O-sulfated heparan sulfates: requirement for optimal binding interactions of heparan sulfate with early-acting cytokines and matrix proteins. Blood. 2000;95(1):147\u201355.","journal-title":"Blood"},{"issue":"5","key":"352_CR34","first-page":"404","volume":"81","author":"G D\u2019Arenna","year":"1996","unstructured":"D\u2019Arenna G, Musto P, Cascavilla N, Di Giorgio G, Zendoli F, Carotenuto M. Human umbilical cord blood: immunophenotypic heterogeneity of CD34+ hematopoietic progenitor cells. Haematologica. 1996;81(5):404\u20139.","journal-title":"Haematologica"},{"issue":"1","key":"352_CR35","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1182\/blood.V87.1.1.1","volume":"87","author":"DS Krause","year":"1996","unstructured":"Krause DS, Fackler MJ, Civin CI, May WS. CD34: structure, biology, and clinical utility. Blood. 1996;87(1):1\u201313.","journal-title":"Blood"},{"issue":"4","key":"352_CR36","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1182\/blood.V90.4.1345","volume":"90","author":"VC Broudy","year":"1997","unstructured":"Broudy VC. Stem cell factor and hematopoiesis. Blood. 1997;90(4):1345\u201364.","journal-title":"Blood"},{"issue":"9","key":"352_CR37","doi-asserted-by":"crossref","first-page":"3563","DOI":"10.1182\/blood.V87.9.3563.bloodjournal8793563","volume":"87","author":"AJ Shah","year":"1996","unstructured":"Shah AJ, Smogorzewska EM, Hannum C, Crooks GM. Flt3 ligand induces proliferation of quiescent human bone marrow CD34+CD38\u2212 cells and maintains progenitor cells in vitro. Blood. 1996;87(9):3563\u201370.","journal-title":"Blood"},{"issue":"11","key":"352_CR38","doi-asserted-by":"crossref","first-page":"5169","DOI":"10.4049\/jimmunol.158.11.5169","volume":"158","author":"V Ramsfjell","year":"1997","unstructured":"Ramsfjell V, Borge OJ, Cui L, Jacobsen SEW. Thrombopoietin directly and potently stimulates multilineage growth and progenitor cell expansion from primitive (CD34+CD38\u2212) human bone marrow progenitor cells. J Immunol. 1997;158(11):5169\u201377.","journal-title":"J Immunol"},{"issue":"9","key":"352_CR39","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1038\/sj.bmt.1705979","volume":"41","author":"M Lima de","year":"2008","unstructured":"de Lima M, McMannis J, Gee A, Komanduri K, Couriel D, Andersson BS, et al. Transplantation of ex vivo expanded cord blood cells using the copper chelator tetraethylenepentamine: a phase I\/II clinical trial. Bone Marrow Transplant. 2008;41(9):771\u20138.","journal-title":"Bone Marrow Transplant"},{"issue":"12","key":"352_CR40","doi-asserted-by":"crossref","first-page":"5061","DOI":"10.1182\/blood-2001-12-0290","volume":"101","author":"J Jaroscak","year":"2003","unstructured":"Jaroscak J, Goltry K, Smith A, Waters-Pick B, Martin PL, Driscoll TA, et al. Augmentation of umbilical cord blood (UCB) transplantation with ex vivo-expanded UCB cells: results of a phase 1 trial using the AastromReplicell System. Blood. 2003;101(12):5061\u20137.","journal-title":"Blood"},{"issue":"7","key":"352_CR41","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1053\/bbmt.2002.v8.pm12171483","volume":"8","author":"EJ Shpall","year":"2002","unstructured":"Shpall EJ, Quinones R, Giller R, Zeng C, Baron AE, Jones RB, et al. Transplantation of ex vivo expanded cord blood. Biol Blood Marrow Transplant. 2002;8(7):368\u201376.","journal-title":"Biol Blood Marrow Transplant"},{"issue":"8","key":"352_CR42","doi-asserted-by":"crossref","first-page":"2717","DOI":"10.1182\/blood.V96.8.2717","volume":"96","author":"AR Migliaccio","year":"2000","unstructured":"Migliaccio AR, Adamson JW, Stevens CE, Dobrila NL, Carrier CM, Rubinstein P. Cell dose and speed of engraftment in placental\/umbilical cord blood transplantation: graft progenitor cell content is a better predictor than nucleated cell quantity. Blood. 2000;96(8):2717\u201322.","journal-title":"Blood"}],"container-title":["Pharmaceutical Research"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11095-010-0352-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11095-010-0352-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11095-010-0352-y","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,6,4]],"date-time":"2023-06-04T16:16:40Z","timestamp":1685895400000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11095-010-0352-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,12,24]]},"references-count":42,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2011,6]]}},"alternative-id":["352"],"URL":"https:\/\/doi.org\/10.1007\/s11095-010-0352-y","relation":{},"ISSN":["0724-8741","1573-904X"],"issn-type":[{"value":"0724-8741","type":"print"},{"value":"1573-904X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,12,24]]}}}